Trial Profile
A clinical trial to investigate RAD1901 in combination with ribociclib (LEE011) for the treatment of advanced breast cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Elacestrant (Primary) ; Ribociclib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 29 Jan 2016 New trial record